Results 31 to 40 of about 14,154 (120)
Prevalence of drug resistance against NRTI, NNRTI and PI.
, 2023 Abbreviations: PI; atazanavir/ritonavir (ATV/r), darunavir/ ritonavir (DRV/r), fosamprenavir/ ritonavir (FPV/r), indinavir/ ritonavir (IDV/r), lopinavir/ ritonavir (LPV/r), nelfinavir (NFV), tipranavir/ ritonavir (TPV/r). NRTI; stavudin (d4T), didanosin (Dilsha Siddiqui (16877717), Fatima Mir (8967854), Sofia Furqan (16877726), Mahnoor Javaid (16877723), Ayesha Iftikhar (11559090), Nida Farooqui (12524843), Syed Hani Abidi (11361852), Faisal Sultan (10996620), Sharaf Ali Shah (14380838), Syed Faisal Mahmood (11287566), Uzma Badar (16877720) +10 morecore +1 more sourceStability of the HIV cascade of care throughout the COVID‐19 pandemic in Europe: Results from the multinational EuroSIDA cohort study (2016–2022)
HIV Medicine, Volume 27, Issue 11, Page 1832-1844, November 2026.Abstract Background
Prior to the COVID‐19 pandemic, antiretroviral therapy (ART) coverage and viral suppression were improving across Europe; however, the impact of the pandemic on HIV care remains uncertain. Methods
In‐person visits, ART coverage and viral suppression among those on ART were described in the EuroSIDA cohort for each calendar year from Olga Fursa, Wendy Bannister, Giovanni Guaraldi, Justyna Kowalska, Jose M. Miro, Robert Zangerle, David Jilich, Jean‐Paul Viard, Katharina Kusejko, Piotr Nowak, Pere Domingo, Claire Mackintosh, Antonella Castagna, Thomas Benfield, Bartosz Szetela, Johannes Bogner, Marta Boffito, Lars Peters, on behalf of the EuroSIDA study group +18 morewiley +1 more sourcePrevalence of major NRTI and NNRTI resistance mutations in individuals with acquired drug resistance.
, 2016 Absolute and cumulative prevalence of each major nucleoside (NRTI) and nonnucleoside RT inhibitor (NNRTI) drug-resistance mutation (DRM) in 4,926 individuals with virological failure and intermediate or high-level acquired NRTI or NNRTI resistance while ...Neil Parkin (273844), Annemarie M. J. Wensing (105565), Rami Kantor (7863), Soo-Yon Rhee (42412), Elliot Raizes (840995), Mark A. Wainberg (196455), Irene Mukui (757883), Douglas D. Richman (168764), Mina C. Hosseinipour (143744), Jonathan M. Schapiro (374093), Joseph E. Fitzgibbon (840997), Marco Schito (840998), Carole L. Wallis (326872), Nicaise Ndembi (703630), Michael R. Jordan (146520), Raph L. Hamers (718072), Avelin F. Aghokeng (322582), Clement Zeh (226174), Gert U. Van Zyl (427181), Michele Tang (840996), Robert W. Shafer (32534), Tobias F. Rinke de Wit (178193), Joseph Fokam (322576), Lisa M. Frenkel (337077), Chunfu Yang (293864), Arlene Chua (134856), Joel E. Gallant (348304), David Katzenstein (182035), Silvia Bertagnolio (57174), Ravindra K. Gupta (372679), Tulio De Oliveira (5666317), Sergio Carmona (562195) +31 morecore +1 more sourceMedicinal Chemistry Aspects of Thiazole and Thiazolidine Derivatives as Fundamental Building Blocks to Design New NNRTIs Against HIV‐1 Reverse Transcriptase
ChemMedChem, Volume 21, Issue 19, 14 October 2026.HIV‐1 reverse transcriptase (HIV‐1 RT) is a polymerase enzyme and a key target in HIV‐1 therapy. The discovery of selective HIV‐1 RT inhibitors has highlighted thiazole scaffolds and their derivatives, thiazolidine‐2‐one and thiazolidine‐2,4‐dione, as promising structures for the rational design of novel non‐nucleoside reverse transcriptase inhibitors (José Arion da Silva Moura, Matheus Vinicius Guimarães de Melo, Diane Regis Santos do Nascimento, Thaynara Paula Warren Bezerra, Mathieu Métifiot, Patricia Recordon‐Pinson, Maira Galdino da Rocha Pitta, Marina Galdino da Rocha Pitta, Michelly Cristiny Pereira, Marie‐Line Andreola +9 morewiley +1 more sourcePredictors of Liver Steatosis Progression Among People Living With HIV in Low‐ and Middle‐Income Countries: A Multicentre Longitudinal Study
Journal of the International AIDS Society, Volume 29, Issue 10, October 2026.ABSTRACT Introduction
Liver steatosis is increasingly recognized as a major comorbidity in people living with HIV (PLWH), with growing evidence suggesting an increased risk of progression to advanced liver disease. We assessed predictors of liver steatosis progression over 36 months in PLWH from low‐ and middle‐income countries.Marie K. Plaisy, Thierry Tiendrebeogo, Carlotta Mondoka, Mark H. Kuniholm, Rodrigo de Carvalho Moreira, Aggrey Semeere, Rohidas T. Borse, Albert Minga, Gilles Wandeler, Gad Murenzi, Brenda E. Crabtree‐Ramírez, Niharika Samala, Jeremy Ross, Ephrem Mensah, Ardele Mandiriri, Sandra W. Cardoso, Jean Paul Mivumbi, Lameck Diero, Haridas Prasad, Paola Alarcón Murra, Belinda V. Chihota, Suzanne Goodrich, Thida Chanyachukul, Ellen Brazier, Stephany N. Duda, Hugo Perazzo, Antoine Jaquet, the International epidemiology Databases to Evaluate AIDS (IeDEA) +27 morewiley +1 more sourceMetabolic Dysfunction‐Associated Steatohepatitis and the Progression of Cognitive Decline in Older Thai People With HIV
Journal of the International AIDS Society, Volume 29, Issue 10, October 2026.ABSTRACT Introduction
Metabolic dysfunction‐associated steatohepatitis (MASH) is more common in people with HIV and associated with systemic inflammation and extrahepatic complications, including cognitive impairment. While cross‐sectional studies suggest an association between MASH and worse cognitive outcomes, its impact on longitudinal cognitive ...Katekarn Porkaew, Akarin Hiransuthikul, Win Min Han, Tanakorn Apornpong, Sasiwimol Ubolyam, Stephen Kerr, Anchalee Avihingsanon, HIV‐NAT 006 and 207 study team +7 morewiley +1 more sourceMarket share of selected antiretrovirals of the nRTI-class (% of all treatment days per year).
, 2013 Market share of selected antiretrovirals of the nRTI-class (% of all treatment days per year).Stefan Reuter (199795), Frank Bergmann (54891), Barbara Bartmeyer (51157), Jan van Lunzen (278823), Osamah Hamouda (51159), Kirsten Hoeper (344499), Christian Kollan (240305), Andreas Plettenberg (344501), Johannes Bogner (344497), Gerd Faetkenheuer (344498), Jürgen Rockstroh (143112), Hans-Jürgen Stellbrink (344502), Heinz-August Horst (344500), Matthias Stoll (143083), Carlos Fritzsche (325987) +14 morecore +1 more sourceAssociation Between HIV Infection Duration and Left Ventricular Concentric Remodeling and Myocardial Fibrosis: A Cross‐Sectional Study Using Cardiac MRI
Journal of Magnetic Resonance Imaging, Volume 64, Issue 4, Page 1037-1049, October 2026.ABSTRACT Background
Antiretroviral therapy has transformed HIV into a chronic condition, yet cardiac injury remains a major issue. Purpose
To assess the ability of cardiac MR imaging markers to predict cardiac injury and disease progression in HIV‐infected individuals. Study Type
Prospective.Chunyan Deng, Wei Sun, Tianhu Gao, Haixia Chen, Lu Liu, Ran Li +5 morewiley +1 more sourceDynamics of NRTI resistance mutations during therapy interruption
, 2009 To date, very little information is available regarding the evolution of drug resistance mutations during treatment interruption (TI). Using a survival analysis approach, we investigated the dynamics of mutations associated with resistance to nucleoside ...Tortta, M., Forbici, F, Antinori, A., Lengauer, T, Mario Santoro, Lengauer, T., Thomas Lengauer, Santoro, M, Federica Forbici, Antinori, A, Perno, C., Sing, T., Zaccarelli, M., Ceccherini-Silberstein, F, Pasquale Narciso, Ceccherini-Silberstein, F., Maria Mercedes Santoro, Trotta, M, Carlo Federico Perno, Marconi, P., Narciso, P, Marconi, P, Bellagamba, R., Tobias Sing, Svicher, V, Zaccarelli, M, Andrea Antinori, Maria Concetta Bellocchi, D'arrigo, R., Bellagamba, R, Patrizia Marconi, Svicher, V., Bellocchi, M, Roberta D'arrigo, PERNO, CARLO FEDERICO, Valentina Svicher, Trignetti, M., SANTORO, MARIA, Santoro, M., Sing, T, CECCHERINI SILBERSTEIN, FRANCESCA, Rita Bellagamba, Trignetti, M, Francesca Ceccherini-Silberstein, Perno, C, SVICHER, VALENTINA, Maria Paola Trotta, Bellocchi, M., Maria Trignetti, Mauro Zaccarelli, Forbici, F., D'arrigo, R, Narciso, P. +52 morecore +1 more source